altretamine has been researched along with methotrexate in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 49 (74.24) | 18.7374 |
1990's | 9 (13.64) | 18.2507 |
2000's | 4 (6.06) | 29.6817 |
2010's | 4 (6.06) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Carter, SK; Wasserman, TH | 1 |
Bitran, JD; Cooksey, JA; DeMeester, TR; Desser, RK; Golomb, HM; Mintz, U | 1 |
Anderson, T; Bender, RA; Canellos, GP; Chabner, BA; DeVita, VT; Fisher, RI; Hubbard, SP; Simon, RM; Young, RC | 1 |
Costa, J; Garvin, AJ; Ozols, RF; Simon, RM; Young, RC | 1 |
Blom, J; Heim, WJ; Miller, CF; Weltz, MD | 1 |
Weiss, RB | 1 |
Bruntsch, U; Gallmeier, WM | 2 |
Cunningham, T; Donavan, M; Longacre, D; Paladine, W; Sponzo, R | 1 |
Assekritova, IV; Gorbunova, VA; Lichinitser, MR | 1 |
Holoye, PY | 1 |
Fisher, RI; Young, RC | 1 |
DiBella, NJ; Nelson, RA; Norgard, MJ | 1 |
Canellos, GP; Chabner, BA; DeVita, VT; Hubbard, SP; Young, RC | 1 |
Young, RC | 2 |
Aartsen, E; Heintz, AP; Neijt, JP; ten Bokkel Huinink, WW; van der Burg, ME; van Lent, M; van Lindert, AC; van Oosterom, AT; Vermorken, JB; Willemse, PH | 1 |
Hansen, LA; Hughes, TE | 1 |
Neijt, JP; ten Bokkel Huinink, WW; van der Burg, ME; van der Hoop, RG; van Houwelingen, C | 1 |
Abeloff, MD; Aisner, SC; Eggleston, JC; Ettinger, DS; Finkelstein, DM; Ruckdeschel, JC | 1 |
Carbone, PP; Davis, TE; Kline, JC; Love, RR; Palta, M; Tormey, DC | 1 |
Bielack, S; Delling, G; Knop, J; Winkler, K | 1 |
Ihde, DC; Viallet, J | 1 |
Chahinian, AP; Comis, RL; Hirsh, V; Holland, JF; Kopel, S; Perry, MC; Propert, KJ; Skarin, A; Ware, JH; Zimmer, B | 1 |
Neijt, JP; ten Bokkel Huinink, WW; Van der Burg, ME; van Oosterom, AT | 1 |
Abeloff, MD; Berkman, AW; Markman, M; Waterfield, WC | 1 |
Livingston, RB | 1 |
Albain, KS; Bitran, JD; Desser, R; Golomb, HM; Greenburg, A; Hoffman, PC; Jacobs, RH; Potkul, L | 1 |
Ashikaga, T; Belinson, JL; McClure, M; Pretorius, RG | 1 |
Blouin, R; de Gramont, A; Dray, C; Drolet, Y; Krulik, M; Lavoie, A; Louvet, C; Painchaud, M; Pigné, A; Tessier, C | 1 |
Heintz, AP; Nooy, M; Schaberg, A; Trimbos, JB; Van der Velde, EA; Van Oosterom, AT | 1 |
Delgado, G; Edwards, BK; Marantz, AB; Posada, JG; Schein, PS; Smith, FP; Yeung, KY | 1 |
Howell, SB; Lucas, WE; Markman, M | 1 |
Ballard, WP; Coleman, M; Pasmantier, MW; Silver, RT | 1 |
Botts, B; Carlson, JA; Day, TG; Masterson, BJ | 1 |
Ozols, RF | 1 |
Grönroos, M; Kangas, L; Mäenpää, J | 1 |
Hamerlynck, JV; Kooyman, CD; Neijt, JP; ten Bokkel Huinink, WW; van der Burg, ME; van Houwelingen, JC; van Lent, M; van Lindert, AC; van Oosterom, AT; Vriesendorp, R | 1 |
Bertrand, M; Chang, FF; Kendregan, B; Klein, L; Mackie, A; Metter, GE; Multhauf, P; Presant, CA; Rappaport, D | 1 |
Carmo-Pereira, J; Costa, FO; Henriques, E; Ricardo, JA | 1 |
Kaplan, RS; Wiernik, PH | 1 |
Dillman, RO; Green, MR; Lea, JW; Lehar, TJ; Mendelsohn, J; Rentschler, RE; Royston, I; Seagren, SL; Stanton, W; Taetle, R; Young, JA | 1 |
Brissaud, P; de Gramont, A; Debray, J; Hubert, D; Krulik, M; Pigne, A; Sirinelli, A; Zylberait, D | 1 |
Bruckner, HW; Cohen, CJ; Goldberg, JD; Holland, JF | 1 |
Bruning, PF; Hamerlynck, JV; Schellekens, PT; ten Berge, RJ | 1 |
Berenberg, J; Comis, R; Green, M; Horton, C; Kennedy, BJ; Pajak, TF; Silver, RT; Spaulding, M | 1 |
Ozols, RF; Young, RC | 1 |
Davis, TE; Gilchrist, KW; Neville, AJ | 1 |
Chahinian, AP; Green, G; Holland, JF | 1 |
Barlow, JJ; Lele, SB | 1 |
Braun, DP; Harris, JE | 1 |
Grigorova, TM; Marenich, AF; Vartanian, LG | 1 |
De Lena, M; De Palo, G; Demicheli, R; Valagussa, P; Villa, E | 1 |
Postmus, PE; Smit, EF | 1 |
Heinonen, E; Hinkka, SM; Karnani, P; Klemi, PJ; Korpijaakko, TA; Kuoppala, TA; Lähde, MA; Laine, AM; Mäenpää, JU; Nuoranne, EK | 1 |
Broder, LE; Charyulu, KN; Donnelly, EJ; Rao, RK; Raub, WA; Saldana, MJ; Selawry, OS; Sridhar, KS | 1 |
Gray, RJ | 1 |
Green, MR | 1 |
10 review(s) available for altretamine and methotrexate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The integration of chemotherapy into combined modality treatment of solid tumors. VIII. Cervical cancer.
Topics: Alkylating Agents; Altretamine; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Radiotherapy, High-Energy; Radium; Uterine Cervical Neoplasms; Vaginal Smears | 1977 |
Small-cell carcinoma of the lung: therapeutic management.
Topics: Alkylating Agents; Altretamine; Antineoplastic Agents; Brain; Carcinoma, Small Cell; Doxorubicin; Drug Therapy, Combination; Humans; Immunotherapy; Lung Neoplasms; Methotrexate; Nitrosourea Compounds; Podophyllotoxin; Procarbazine; Vinblastine; Vincristine | 1978 |
Chemotherapy of ovarian cancer.
Topics: Alkylating Agents; Altretamine; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Ovarian Neoplasms | 1978 |
Chemotherapy of ovarian cancer: past and present.
Topics: Acrylates; Alkylating Agents; Altretamine; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Maryland; Methotrexate; Ovarian Neoplasms; Porfiromycin; Procarbazine; Progestins | 1975 |
Hexamethylmelamine (altretamine): early National Cancer Institute trials.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; National Institutes of Health (U.S.); Neoplasm Staging; Ovarian Neoplasms; United States | 1991 |
Altretamine.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Interactions; Female; Fluorouracil; Humans; Lung Neoplasms; Methotrexate; Ovarian Neoplasms | 1991 |
Current chemotherapy of small cell lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Complement Membrane Attack Complex; Complement System Proteins; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitomycin; Mitomycins; Podophyllotoxin; Procarbazine; Prognosis; Time Factors; Vincristine | 1986 |
Chemotherapy of ovarian cancer.
Topics: Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Estrogen Antagonists; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Ovarian Neoplasms; Progestins; Tamoxifen | 1984 |
Oral therapy for small cell lung cancer.
Topics: Administration, Oral; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine | 1995 |
24 trial(s) available for altretamine and methotrexate
Article | Year |
---|---|
Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
Topics: Adenocarcinoma; Adult; Aged; Altretamine; Bleomycin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Nitrosourea Compounds; Procarbazine; Triazines | 1978 |
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Altretamine; Antineoplastic Agents; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Middle Aged; Ovarian Neoplasms; Prospective Studies | 1978 |
Histologic grade in advanced ovarian cancer.
Topics: Altretamine; Cell Differentiation; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Ovarian Neoplasms; Prognosis | 1979 |
Hexamethylmelamine, vincristine, and methotrexate chemotherapy in advanced neoplasms.
Topics: Adult; Aged; Altretamine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Neoplasms; Time Factors; Triazines; Vincristine | 1977 |
Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
Topics: Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Maryland; Melphalan; Methotrexate; National Institutes of Health (U.S.); Ovarian Neoplasms; Prospective Studies; United States | 1975 |
Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Staging; Netherlands; Ovarian Neoplasms; Prognosis; Time Factors | 1991 |
Hexamethylmelamine (altretamine): early National Cancer Institute trials.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; National Institutes of Health (U.S.); Neoplasm Staging; Ovarian Neoplasms; United States | 1991 |
Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Nervous System Diseases; Ovarian Neoplasms; Prospective Studies | 1990 |
A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group.
Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Random Allocation; Remission Induction; Survival Rate; Vincristine | 1990 |
[Scintigraphic follow-up of osteosarcoma during neoadjuvant chemotherapy. Results of the cooperative osteosarcoma study of the Society for Pediatric Oncology].
Topics: Adolescent; Adult; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Follow-Up Studies; Humans; Methotrexate; Multicenter Studies as Topic; Osteosarcoma; Radionuclide Imaging; Technetium Tc 99m Medronate | 1988 |
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Prognosis; Random Allocation; Remission Induction; Warfarin | 1989 |
Complete remission at laparotomy: still a gold standard in ovarian cancer?
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Laparotomy; Methotrexate; Ovarian Neoplasms; Random Allocation | 1986 |
The case for combination chemotherapy in the treatment of advanced ovarian cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Ovarian Neoplasms | 1985 |
Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Ovarian Neoplasms; Paresthesia; Prognosis; Random Allocation; Reoperation; Time Factors | 1984 |
Effects of amphotericin B with combination chemotherapy on response rates and on survival in non-small cell carcinoma of the lung.
Topics: Altretamine; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Doxorubicin; Drug Evaluation; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Palliative Care; Random Allocation; Time Factors | 1984 |
Advanced ovarian carcinoma: a prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF).
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Altretamine; Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Ovarian Neoplasms; Prognosis; Prospective Studies | 1981 |
Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience.
Topics: Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Random Allocation; Reoperation; Thiotepa | 1983 |
Combination chemotherapy and immune capacity in advanced ovarian carcinoma.
Topics: Adult; Aged; Altretamine; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytotoxicity, Immunologic; Doxorubicin; Female; Fluorouracil; Humans; Immunity, Cellular; Leukocyte Count; Lymphocyte Activation; Methotrexate; Middle Aged; Ovarian Neoplasms | 1984 |
Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: a Cancer and Leukemia Group B study.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate | 1983 |
Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Thrombocytopenia; Vomiting | 1984 |
Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
Topics: Adenocarcinoma; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Methotrexate; Neoplasm Staging; Ovarian Neoplasms | 1984 |
Medical Research Council study on chemotherapy in advanced ovarian cancer. Medical Research Council's Working Party on ovarian cancer.
Topics: Aged; Altretamine; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; Methotrexate; Middle Aged; Ovarian Neoplasms; Random Allocation | 1981 |
The subrenal capsule assay in selecting chemotherapy for ovarian cancer: a prospective randomized trial.
Topics: Aged; Altretamine; Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Methotrexate; Mice; Mice, Inbred Strains; Middle Aged; Ovarian Neoplasms; Prospective Studies; Subrenal Capsule Assay; Tegafur | 1995 |
A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in
Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Procarbazine; Remission Induction; Vinblastine; Vincristine | 1994 |
33 other study(ies) available for altretamine and methotrexate
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine | 1979 |
[Chemotherapy of the ovarian carcinoma (author's transl)].
Topics: Altretamine; Antineoplastic Agents; Chlorambucil; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hydroxyprogesterones; Mechlorethamine; Melphalan; Mercaptopurine; Methotrexate; Mitomycins; Nitrosourea Compounds; Ovarian Neoplasms; Thiotepa; Vinblastine; Vincristine | 1977 |
[Carminomycin in drug combination in breast cancer and soft tissue sarcomas].
Topics: Aged; Altretamine; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms | 1977 |
Management of small-cell bronchogenic carcinoma.
Topics: Altretamine; Antibiotics, Antineoplastic; Brain Neoplasms; Carcinoma, Bronchogenic; Cyclophosphamide; Drug Therapy, Combination; Humans; Lung Neoplasms; Mechlorethamine; Methotrexate; Neoplasm Metastasis; Pleural Effusion; Prognosis; Vena Cava, Superior | 1978 |
Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinoma.
Topics: Aged; Altretamine; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Nitrosourea Compounds; Remission, Spontaneous; Tracheal Neoplasms; Triazines | 1975 |
Short term high density systemic therapy for metastatic breast cancer.
Topics: Altretamine; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Fluoxymesterone; Humans; Leucovorin; Leukopenia; Lung; Methotrexate; Mitolactol; Neoplasm Metastasis; Prednisone; Receptors, Estrogen; Tamoxifen; Thrombocytopenia; Time Factors; Vincristine | 1985 |
Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitomycin; Mitomycins | 1989 |
Intensive alternating chemotherapy regimen in small cell carcinoma of the lung.
Topics: Actuarial Analysis; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia; Vincristine | 1985 |
A 10-year experience with combined modality therapy for stage III small cell lung carcinoma.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Prognosis; Vincristine | 1986 |
Hexamethylmelamine, methotrexate, 5-fluorouracil as second line chemotherapy after platinum for epithelial ovarian malignancies.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Hormones; Humans; Methotrexate; Middle Aged; Ovarian Neoplasms; Peptichemio | 1986 |
[Chemotherapy in 143 advanced epithelial cancers of the ovary. Experience at the Hôtel-Dieu of Quebec and Hôpital Saint-Antoine (Paris)].
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Staging; Ovarian Neoplasms | 1986 |
The treatment of advanced ovarian carcinoma (I): clinical variables associated with prognosis.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Hysterectomy; Methotrexate; Ovarian Neoplasms; Ovariectomy; Postoperative Care; Prognosis; Regression Analysis | 1988 |
The cyclophosphamide, hexamethylmelamine, 5 fluorouracil (CHF) regimen in the treatment of advanced and recurrent ovarian cancer.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Hysterectomy; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Reoperation | 1985 |
Intraperitoneal chemotherapy for advanced ovarian cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Humans; Methotrexate; Ovarian Neoplasms; Peritoneal Cavity; Thiosulfates | 1985 |
Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
Topics: Adenocarcinoma; Age Factors; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Ovarian Neoplasms | 1985 |
Hexamethylmelamine, methotrexate and 5-fluorouracil (HMF) for progressive ovarian carcinoma during therapy with cis-platinum, cyclophosphamide +/- doxorubicin.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Ovarian Neoplasms; Reoperation | 1985 |
Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
Topics: Aclarubicin; Adolescent; Adult; Aged; Altretamine; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cisplatin; Cyclophosphamide; Cystadenocarcinoma; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Methotrexate; Mice; Middle Aged; Mitomycins; Naphthacenes; Neoplasm Transplantation; Ovarian Neoplasms; Tegafur; Tumor Stem Cell Assay; Vincristine | 1985 |
Neurotoxicity of antineoplastic drugs.
Topics: Altretamine; Antineoplastic Agents; Asparaginase; Brain; Central Nervous System Diseases; Cisplatin; Cranial Nerves; Humans; Injections, Intraventricular; Injections, Spinal; Methotrexate; Peripheral Nervous System Diseases; Procarbazine; Risk; Tomography, X-Ray Computed; Vinca Alkaloids | 1982 |
Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Vincristine | 1982 |
[Treatment of advanced ovarian cancer].
Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis | 1984 |
[Chemotherapy of epithelial ovarian carcinoma].
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chlorambucil; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Ovarian Neoplasms | 1983 |
The chemotherapy of granulosa cell tumors of the ovary: experience of the Wisconsin Clinical Cancer Center.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Granulosa Cell Tumor; Humans; Melphalan; Methotrexate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prednisone; Retrospective Studies; Vincristine | 1984 |
Effects of combination chemotherapy on immunoregulatory cells in peripheral blood of solid tumor cancer patients: correlation with rebound overshoot immune function recovery.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Cell Adhesion; Drug Therapy, Combination; Fluorouracil; Humans; Immunity, Cellular; Indomethacin; Leucovorin; Lymphocyte Activation; Methotrexate; Middle Aged; Mitomycins; Monocytes; Neoplasms; Phytohemagglutinins; T-Lymphocytes, Regulatory; Time Factors | 1981 |
[Surgical method and combination chemotherapy in treating stage-III and IV ovarian cancer].
Topics: Altretamine; Antineoplastic Agents; Carcinoma; Cyclophosphamide; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Methotrexate; Ovarian Neoplasms; Ovary; Postoperative Care; Tegafur; Time Factors | 1980 |
Prospective study with HEXA-CAF combination in ovarian carcinoma.
Topics: Altretamine; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Ovarian Neoplasms; Ovary | 1981 |
A Bayesian analysis of institutional effects in a multicenter cancer clinical trial.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Biometry; Carcinoma, Small Cell; Cyclophosphamide; Data Interpretation, Statistical; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Methotrexate; Multicenter Studies as Topic; Probability; Proportional Hazards Models; Randomized Controlled Trials as Topic; Vincristine | 1994 |
Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Cyclophosphamide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Research Design | 2008 |